Extracellular Vesicles and Chemotherapy-Induced Peripheral Neuropathy

计划入组 120 人 · 首次发布于 2026 年 4 月 30 日

Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy

计划入组 50 人 · 首次发布于 2002 年 7 月 19 日

PEA for the Relief of Chemotherapy-Induced Peripheral Neuropathy

计划入组 88 人 · 首次发布于 2022 年 2 月 18 日

peripherally-restricted NLRP3 inhibitor (peripheral neuropathy)

Peripherally-restricted allosteric SARM1 inhibitor (peripheral neuropathy)

AAV based SARM1 gene therapy (peripheral neuropathy/neurological disorders)

Bard Peripheral Vascular, Inc.

United States

HARVEST TRAVEL & LEISURE INCOME ETF UNIT CL A

United States

NeuroBo Pharmaceuticals

United States

Phase III Trial Tests Yoga as Non-Pharmacological Treatment for Chemotherapy-Induced Peripheral Neuropathy

Asahi Kasei Pharma Initiates Phase III Trial of ART-123 for Chemotherapy-Induced Peripheral Neuropathy Prevention

Psilocybin prevents chemotherapy-induced peripheral neuropathy in preclinical models, paving the way for a Phase 2 trial